A Multicenter, Randomized, Double-blind, Placebo- controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients with Huntington’s Disease

Project: Research

Project Details

StatusActive
Effective start/end date17/08/2116/08/26

Keywords

  • phase 1 and 2 study
  • treatment efficacy
  • multicentre trial
  • Huntington's disease